NPPA merges Pharma Jan Samadhan and Pharma Sahi Daam into one portal
Synopsis
India's drug pricing regulator NPPA has quietly closed a gap that frustrated consumers for years: medicine price verification and complaint filing now live on the same portal. The Pharma Sahi Daam platform absorbs Pharma Jan Samadhan, making it easier for citizens to check prices and report violations in one step — a small but meaningful upgrade for pharmaceutical accountability.
Key Takeaways
NPPA merged Pharma Jan Samadhan and Pharma Sahi Daam into a single portal, operational from 25 June 2025 .
Citizens can now verify medicine prices and file pricing complaints through the unified Pharma Sahi Daam web portal and mobile app.
The two platforms previously operated through separate web portals, though they were already linked at the app level.
Pharma Sahi Daam covers both scheduled and non-scheduled medicine prices under government-approved limits set by the DPCO, 2013 .
The unified app is available on the Google Play Store ; the web portal is live with immediate effect.
The National Pharmaceutical Pricing Authority (NPPA) has merged its two citizen-facing digital platforms — Pharma Jan Samadhan and Pharma Sahi Daam — into a single unified portal, effective 25 June 2025, the Ministry of Chemicals and Fertilisers said in an official statement. The integration gives the public seamless access to both medicine price verification and grievance redressal through one interface.
What the Integration Changes
Until now, the two platforms operated through separate web portals, even though they had already been linked at the mobile application level. The unified Pharma Sahi Daam web portal and its mobile app — available on the Google Play Store — now bring both services under a single digital address. Citizens no longer need to switch between platforms to check a medicine's price and then file a complaint about overcharging.
What Each Service Does
Pharma Sahi Daam was designed to give consumers instant access to the prices of both scheduled and non-scheduled medicines, enabling them to verify whether a drug is being sold within government-approved price limits. Pharma Jan Samadhan, on the other hand, facilitates the reporting and resolution of complaints related to medicine pricing violations. Together, the two tools cover the full consumer journey — from price discovery to dispute resolution.
The Regulator Behind It
NPPA was constituted through a Government of India resolution in 1997 as an attached office of the Department of Pharmaceuticals (DoP) under the Ministry of Chemicals and Fertilisers. As an independent drug pricing regulator, NPPA is responsible for fixing and revising drug prices under the Drugs Prices Control Order (DPCO), 2013, monitoring compliance, and advising on pharmaceutical policy.
Why It Matters for Citizens
The ministry stated that the unified platform is intended to enhance transparency, accountability, and public participation in ensuring access to affordable medicines. The move is particularly significant for patients in smaller towns and rural areas, where medicine overcharging has historically been harder to detect and report. By consolidating the tools, the government aims to lower the barrier for citizens to act on pricing irregularities.
With the portal now operational, the NPPA is expected to track whether the integration leads to a measurable uptick in grievance filings and price-check queries — a metric that will indicate whether the consolidation has genuinely improved citizen access.
Point of View
But the harder question is whether citizens actually use them. NPPA's price-control regime under DPCO 2013 has long depended on consumer reporting to catch overcharging at the retail level — a mechanism that has historically underperformed because the reporting friction was too high. Consolidation reduces that friction, but awareness remains the missing link: surveys consistently show that a majority of Indian medicine buyers do not know government price ceilings exist, let alone how to verify them. The real test of this integration is not the portal launch but the grievance resolution rate in the months that follow.
NationPress
25 Jun 2026
Frequently Asked Questions
What is the unified Pharma Sahi Daam portal?
The unified Pharma Sahi Daam portal is a single digital platform launched by NPPA on 25 June 2025 that combines medicine price verification (formerly Pharma Sahi Daam) and pricing grievance redressal (formerly Pharma Jan Samadhan) into one interface. It is accessible via the web and as a mobile app on the Google Play Store.
What is Pharma Jan Samadhan and how does it work?
Pharma Jan Samadhan is NPPA's grievance redressal service that allows citizens to report complaints about medicine overcharging or pricing violations. It facilitates the filing and resolution of such complaints, and has now been absorbed into the unified Pharma Sahi Daam platform.
How can I check if a medicine is being sold at the correct price?
You can use the Pharma Sahi Daam web portal or mobile app to look up the government-approved price of both scheduled and non-scheduled medicines. If the price charged exceeds the listed ceiling, you can file a complaint through the same platform using the Pharma Jan Samadhan service.
What is NPPA and what authority does it have over drug prices?
The National Pharmaceutical Pricing Authority (NPPA) is an independent regulator constituted in 1997 under the Ministry of Chemicals and Fertilisers. It fixes and revises drug prices under the Drugs Prices Control Order (DPCO), 2013, monitors compliance, and advises on pharmaceutical pricing policy.
Is the integrated portal available for iOS users?
The official statement specifically mentions availability on the Google Play Store. The web portal is accessible to all users regardless of device. iOS availability was not confirmed in the ministry's statement.
